U.S. flag

An official website of the United States government

NM_000138.5(FBN1):c.5513G>A (p.Gly1838Asp) AND not provided

Germline classification:
Conflicting interpretations of pathogenicity (2 submissions)
Last evaluated:
Dec 9, 2021
Review status:
criteria provided, conflicting classifications
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000181546.6

Allele description [Variation Report for NM_000138.5(FBN1):c.5513G>A (p.Gly1838Asp)]

NM_000138.5(FBN1):c.5513G>A (p.Gly1838Asp)

Gene:
FBN1:fibrillin 1 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
15q21.1
Genomic location:
Preferred name:
NM_000138.5(FBN1):c.5513G>A (p.Gly1838Asp)
Other names:
p.G1838D:GGC>GAC
HGVS:
  • NC_000015.10:g.48452594C>T
  • NG_008805.2:g.198195G>A
  • NM_000138.5:c.5513G>AMANE SELECT
  • NP_000129.3:p.Gly1838Asp
  • NP_000129.3:p.Gly1838Asp
  • LRG_778t1:c.5513G>A
  • LRG_778:g.198195G>A
  • LRG_778p1:p.Gly1838Asp
  • NC_000015.9:g.48744791C>T
  • NM_000138.4:c.5513G>A
Protein change:
G1838D
Links:
dbSNP: rs78970689
NCBI 1000 Genomes Browser:
rs78970689
Molecular consequence:
  • NM_000138.5:c.5513G>A - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Synonyms:
none provided
Identifiers:
MedGen: C3661900

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000233849GeneDx
criteria provided, single submitter

(GeneDx Variant Classification (06012015))
Pathogenic
(May 7, 2014)
germlineclinical testing

Citation Link,

SCV003833996Revvity Omics, Revvity
criteria provided, single submitter

(ACMG Guidelines, 2015)
Uncertain significance
(Dec 9, 2021)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing
not providedgermlineyesnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.

Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL; ACMG Laboratory Quality Assurance Committee.

Genet Med. 2015 May;17(5):405-24. doi: 10.1038/gim.2015.30. Epub 2015 Mar 5.

PubMed [citation]
PMID:
25741868
PMCID:
PMC4544753

Details of each submission

From GeneDx, SCV000233849.10

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided

Description

p.Gly1838Asp (GGC>GAC): c.5513 G>A in exon 45 of the FBN1 gene (NM_000138.4)While the G1838D mutation in the FBN1 gene has not been reported to our knowledge, a mutation affecting this same residue, G1838C, has been reported in association with Marfan syndrome (Ganesh A et al., 2006). Additionally, mutations in nearby residues (C1835F, C1835Y, P1837S, C1847W, C1847R) have been reported in association with Marfan syndrome, further supporting the functional importance of this residue and this region of the protein. G1838D results in a non-conservative amino acid substitution, which is likely to impact secondary protein structure as these residues differ in polarity, charge, size and/or other properties. This substitution occurs at a position that is conserved across species. In silico analysis predicts this mutation is damaging to the protein structure/function. Furthermore, G1838D was not observed in approximately 6,500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations.In summary, G1838D in the FBN1 gene is interpreted as a likely disease-causing mutation. The variant is found in TAAD panel(s).

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot providednot providednot providednot providednot provided

From Revvity Omics, Revvity, SCV003833996.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024